Polyganics and Syncom awarded €1.2 million for research into liver and pancreas sealant patch

The companies Polyganics and Syncom on Campus Groningen have been awarded a 1,2 million grant for research after a liver and pancreas sealant patch. A large portion of  this grant stems from the Europees Fonds voor Regionale Ontwikkeling (EFRO). The grant will support a safety and performance study, which is scheduled to take place later this year in multiple renowned clinical centres across Europe.

Polyganics’ easy-to-use device is made of the company’s synthetic and safe bioresorbable polymers and optimized to effectively adhere to and seal-off the surgically treated tissue throughout the critical healing period after hepato-pancreato-biliary (HPB) surgery. The patch functions both as a sealant, withstanding the impact of aggressive bile and pancreatic fluids, and as a hemostat, controlling mild-to-moderate bleeding. Polyganics works together in this developemnt with the biotech company Syncom.